Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Cipla
Citi
Deloitte
Chubb
Baxter
Express Scripts
US Army
Boehringer Ingelheim

Generated: July 21, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NEVANAC

« Back to Dashboard

Clinical Trials for NEVANAC

Trial ID Title Status Sponsor Phase Summary
NCT00332774 Nevanac 3-Month Safety Study With QID Dosing Completed Alcon Research Phase 3 The purpose of this study is to determine the safety of Nevanac 0.1% compared to Acular LS 0.4% and Vehicle in patients treated before cataract surgery and for approximately 90 days following surgery.
NCT00333255 Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery Completed Alcon Research Phase 3 The purpose of this study is to compare the effectiveness of Nepafenac Ophthalmic Suspension, 0.1% eye drops to Acular LS eye drops, used before and after cataract surgery, for treating inflammation in the eye.
NCT00347204 Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK Completed Allergan Phase 4 To determine the ability of two topical Nonsteroidal Anti-inflammatory drops (Acular LS & Nevanac) to help control pain following Photorefractive Keratectomy (PRK).
NCT00347204 Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK Completed Center For Excellence In Eye Care Phase 4 To determine the ability of two topical Nonsteroidal Anti-inflammatory drops (Acular LS & Nevanac) to help control pain following Photorefractive Keratectomy (PRK).
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Clinical Trial Conditions for NEVANAC

Condition Name

Condition Name for NEVANAC
Intervention Trials
Cataract 6
Myopia 2
Macular Edema 2
Diabetic Retinopathy 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for NEVANAC
Intervention Trials
Cataract 9
Macular Edema 7
Edema 5
Diabetic Retinopathy 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for NEVANAC

Trials by Country

Trials by Country for NEVANAC
Location Trials
United States 9
Brazil 3
Mexico 2
Malaysia 2
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for NEVANAC
Location Trials
Texas 3
Pennsylvania 2
California 1
Illinois 1
Michigan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for NEVANAC

Clinical Trial Phase

Clinical Trial Phase for NEVANAC
Clinical Trial Phase Trials
Phase 4 13
Phase 3 4
Phase 2 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for NEVANAC
Clinical Trial Phase Trials
Completed 15
Unknown status 3
Not yet recruiting 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for NEVANAC

Sponsor Name

Sponsor Name for NEVANAC
Sponsor Trials
Alcon Research 4
Allergan 3
Innovative Medical 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for NEVANAC
Sponsor Trials
Other 14
Industry 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Fuji
US Army
QuintilesIMS
Federal Trade Commission
Teva
Queensland Health
Fish and Richardson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.